| 臺大學術典藏 |
2021-03-19T01:54:21Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
Chen K.-F.; Tai W.-T.; TSUNG-HAO LIU; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; Chen P.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T01:47:37Z |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
TUNG-HUNG SU; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-03-09T01:43:24Z |
Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis
|
TUNG-HUNG SU; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; Liu C.-J.; Tseng T.-C.; Yang H.-C.; Liu C.-H.; Huang K.-W.; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; Chen P.-J.; Chen D.-S.; Chen K.-F.; Kao J.-H. |
| 臺大學術典藏 |
2020-06-19T02:27:03Z |
Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis
|
Su T.-H.;Shiau C.-W.;Jao P.;Yang N.-J.;Tai W.-T.;Liu C.-J.;Tseng T.-C.;Yang H.-C.;Liu C.-H.;Kai-Wen Huang;Hu T.-C.;Huang Y.-J.;Wu Y.-M.;Chen L.-J.;Chen P.-J.;Chen D.-S.;Chen K.-F.;Kao J.-H.; Su T.-H.; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; Liu C.-J.; Tseng T.-C.; Yang H.-C.; Liu C.-H.; KAI-WEN HUANG; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; Chen P.-J.; Chen D.-S.; Chen K.-F.; Kao J.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:27Z |
Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells
|
Chen K.-F. ;Chen H.-L. ;Tai W.-T. ;Feng W.-C. ;Chih-Hung Hsu ;Chen P.-J. ;Cheng A.-L.; Chen K.-F.; Chen H.-L.; Tai W.-T.; Feng W.-C.; CHIH-HUNG HSU; Chen P.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-26T06:54:22Z |
Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer
|
Wang C.-Y.; Chao T.-T.; Tai W.-T.; Chang F.-Y.; Su W.-P.; Chen Y.-L.; Chen P.-T.; Weng C.-Y.; ANG YUAN; Shiau C.-W.; Yu C.-J.; Chen K.-F. |
| 臺大學術典藏 |
2020-03-06T08:25:00Z |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Liu C.-H.; Liu C.-J.; Tai W.-T.; YUNG-MING JENG; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S.; Su T.-H.;Shiau C.-W.;Jao P.;Liu C.-H.;Liu C.-J.;Tai W.-T.;Yung-Ming Jeng;Yang H.-C.;Tseng T.-C.;Huang H.-P.;Cheng H.-R.;Chen P.-J.;Chen K.-F.;Kao J.-H.;Chen D.-S.; Su T.-H.; Shiau C.-W.; Jao P. |
| 臺大學術典藏 |
2020-02-11T07:58:33Z |
Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis
|
Su T.-H.;Shiau C.-W.;Jao P.;Yang N.-J.;Tai W.-T.;Liu C.-J.;Tseng T.-C.;Yang H.-C.;Liu C.-H.;Huang K.-W.;Hu T.-C.;Huang Y.-J.;Yao-Ming Wu;Chen L.-J.;Chen P.-J.;Chen D.-S.;Chen K.-F.;Kao J.-H.; Su T.-H.; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; Liu C.-J.; Tseng T.-C.; Yang H.-C.; Liu C.-H.; Huang K.-W.; Hu T.-C.; Huang Y.-J.; YAO-MING WU; Chen L.-J.; Chen P.-J.; Chen D.-S.; Chen K.-F.; Kao J.-H. |
| 臺大學術典藏 |
2018-09-10T15:35:00Z |
Dovitinib acts as a novel radiosensitizer in hepatocellular carcinoma by targeting SHP-1/STAT3 signaling
|
Huang, C.-Y.;Tai, W.-T.;Wu, S.-Y.;Shih, C.-T.;Chen, M.-H.;Tsai, M.-H.;Kuo, C.-W.;Shiau, C.-W.;Hung, M.-H.;Chen, K.-F.; Huang, Chao-Yuan; CHAO-YUAN HUANG; Tai, Wei-Tien; Wu, Szu-Yuan; Shih, Chih-Ting; Chen, Min-Hsuan; Tsai, Ming-Hsien; Kuo, Chiung-Wen; Shiau, Chung-Wai; Hung, Man-Hsin; Chen, Kuen-Feng |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
SC-1, a sorafenib derivative, shows anti-tumor effects in osteogenic sarcoma cells
|
Wang, C.-T.;Lin, C.-S.;Shiau, C.-W.;Chu, P.-Y.;Hsiao, C.-C.;Chiang, Y.-L.;Tai, W.-T.;Chen, K.-F.; Wang, C.-T.; Lin, C.-S.; Shiau, C.-W.; Chu, P.-Y.; Hsiao, C.-C.; Chiang, Y.-L.; Tai, W.-T.; Chen, K.-F.; CHEN-SI LIN; Kuen-Feng Chen |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody
|
Chen, K.-F.;Chen, H.-L.;Shiau, C.-W.;Liu, C.-Y.;Chu, P.-Y.;Tai, W.-T.;Ichikawa, K.;Chen, P.-J.;Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:41:21Z |
Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf
|
Chen, K.-F.;Tai, W.-T.;Huang, J.-W.;Hsu, C.-Y.;Chen, W.-L.;Cheng, A.-L.;Chen, P.-J.;Shiau, C.-W.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 國立臺灣大學 |
2012 |
Activation of tyrosine phosphatase SHP-1 determines the apoptotic effect of sorafenib on HCC cells.
|
Tai, W-T.; Shiau, C-W.; Cheng, A-L.; Chen, P-J.; Chen, K-F.; 陳昆鋒; 陳培哲 |
| 國立臺灣科技大學 |
2006 |
Organizational justice, motivation to learn, and training outcomes
|
Liao, W.-C.;Tai, W.-T. |
| 國立臺灣大學 |
2005-05 |
An investigation of individual and contextual factors influencing training variables.
|
Chuang, A.; Liao, W. C.; Tai, W. T. |
| 國立臺灣科技大學 |
2005 |
An investigation of individual and contextual factors influencing training variables
|
Chuang, A.;Liao, W.C.;Tai, W.T. |
